272120-41-9

Basic information

• Product Name: (4,7,10-TRIS-BENZYLOXYCARBONYLMETHYL-1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID
• Synonyms: (4,7,10-TRIS-BENZYLOXYCARBONYLMETHYL-1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID;1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, tris(phenylMethyl) ester;1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1,4,10-tris(phenylmethyl) ester
• CAS NO: 272120-41-9
• Molecular Formula: C₃₇H₄₆N₄O₈
• Molecular Weight: 674.78
• Mol File: 272120-41-9.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 781.4±60.0 °C(Predicted)
• Appearance: /
• Density: 1.196±0.06 g/cm3(Predicted)
• PKA: 4.24±0.10(Predicted)
• CAS DataBase Reference: (4,7,10-TRIS-BENZYLOXYCARBONYLMETHYL-1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (4,7,10-TRIS-BENZYLOXYCARBONYLMETHYL-1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID(272120-41-9)
• EPA Substance Registry System: (4,7,10-TRIS-BENZYLOXYCARBONYLMETHYL-1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID(272120-41-9)

Safety Data

• Hazardous Substances Data: 272120-41-9(Hazardous Substances Data)

Usage

General Description

(4,7,10-Tris-benzyloxycarbonylmethyl-1,4,7,10tetraaza-cyclododec-1-yl)-acetic acid is a chemical compound with potential applications in drug development and biomedical research. It is a derivative of 1,4,7,10-tetraazacyclododecane, which is known for its ability to chelate metal ions. (4,7,10-TRIS-BENZYLOXYCARBONYLMETHYL-1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID contains multiple benzyloxy groups, which can be used to protect the molecule during chemical reactions and then be selectively removed to reveal functional groups for further modifications. The acetic acid moiety can also facilitate conjugation with other molecules for targeted drug delivery or imaging applications. Overall, this compound is a versatile building block with potential for diverse applications in medicinal chemistry and bioconjugation.

Upstream product

• 1415986-40-1 1,4,7-tris(benzoxycarbonyl-methyl)-1,4,7,10-tetraazacyclodecane hydrobromide 
• 957130-00-6 tribenzyl 2,2',2-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 
• 5437-45-6 Benzyl bromoacetate 
• 1023970-60-6 (4-allyloxycarbonylmethyl-7,10-bis-benzyloxycarbonylmethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetic acid benzyl ester 
• 79-08-3 bromoacetic acid 
• 294-90-6 1,4,7,10-tetraazacyclododecan 

Relevant articles and documents

Method for preparing DOTA derivative

The present invention discloses a method for preparing DOTA derivative. Firstly, take 1,4,7,10-tetraazacyclododecane and benzyl bromoacetate in a substitution reaction to obtain a first product. And, the first product is coupled to tert-butyl bromoacetate

RADIOACTIVE PHOSPHOLIPID METAL CHELATES FOR CANCER IMAGING AND THERAPY

Alkylphosphocholine analogs incorporating a chelating moiety that chelates a radioactive metal isotope are disclosed herein. The alkylphophocholine analogs, which can be used to treat or detect solid tumors, have the formula: [Formula should be inserted here]. R1 includes a chelating agent that is chelated to a metal atom, wherein the metal atom is a positron or single photon emitting metal isotope with a half life of greater than or equal to 4 hours, or an alpha, beta or Auger emitting metal isotope with a half life of greater than 6 hours and less than 30 days; a is 0 or 1; n is an integer from 12 to 30; m is 0 or 1; Y is -H, -OH, -COOH, -COOX, -OCOX, or -OX, wherein X is an alkyl or an arylalkyl; R2 is -N+H3, -N+H2Z, -N+HZ2, or -N+Z3, wherein each Z is independently an alkyl or an aroalkyl; and b is 1 or 2.

LONG-LIVED GADOLINIUM BASED TUMOR TARGETED IMAGING AND THERAPY AGENTS

Alkylphosphocholine analogs incorporating a chelating moiety that is chelated to gadolinium are disclosed herein. The alkylphophocholine analogs are compounds having the formula: (I) or a salt therof. R1 includes a chelating agent that is chelated to a gadolinium atom; a is 0 or 1; n is an integer from 12 to 30; m is 0 or 1; Y is -H, -OH, -COOH, -COOX, -OCOX, or -OX, wherein X is an alkyl or an arylalkyl; R2 is -N+H3, -N+H2Z, -N+HZ2, or -N+Z3, wherein each Z is independently an alkyl or an aroalkyl; and b is 1 or 2. The compounds can be used to detect solid tumors or to treat solid tumors. In detection/imaging applications, the gadolinium emits signals that are detectable using magnetic resonance imaging. In therapeutic treatment, the gadolinium emits tumor-targeting charged particles when exposed to epithermal neutrons.